Literature DB >> 19061983

A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42).

Pengfei Lin1, Jianwei Li, Qiji Liu, Fei Mao, Jisheng Li, Rongfang Qiu, Huili Hu, Yang Song, Yang Yang, Guimin Gao, Chuanzhu Yan, Wanling Yang, Changshun Shao, Yaoqin Gong.   

Abstract

Hereditary spastic paraplegias (HSPs), characterized by progressive and bilateral spasticity of the legs, are usually caused by developmental failure or degeneration of motor axons in the corticospinal tract. There are considerable interfamilial and intrafamilial variations in age at onset and severity of spasticity. Genetic studies also showed that there are dozens of genetic loci, on multiple chromosomes, that are responsible for HSPs. Through linkage study of a pedigree of HSP with autosomal-dominant inheritance, we mapped the causative gene to 3q24-q26. Screening of candidate genes revealed that the HSP is caused by a missense mutation in the gene for acetyl-CoA transporter (SLC33A1). It is predicted that the missense mutation, causing the change of the highly conserved serine to arginine at the codon 113 (p. S113R), disrupts the second transmembrane domain in the transporter and reverses the orientation of all of the descending domains. Knockdown of Slc33a1 in zebrafish caused a curve-shaped tail and defective axon outgrowth from the spinal cord. Although the wild-type human SLC33A1 was able to rescue the phenotype caused by Slc33a1 knockdown in zebrafish, the mutant SLC33A1 (p.S113R) was not, suggesting that S113R mutation renders SLC33A1 nonfunctional and one that wild-type allele is not sufficient for sustaining the outgrowth and maintenance of long motor axons in human heterozygotes. Thus, our study illustrated a critical role of acetyl-CoA transporter in motor-neuron development and function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19061983      PMCID: PMC2668077          DOI: 10.1016/j.ajhg.2008.11.003

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

Review 1.  Advances in the hereditary spastic paraplegias.

Authors:  John K Fink
Journal:  Exp Neurol       Date:  2003-11       Impact factor: 5.330

2.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

3.  Classification of the hereditary ataxias and paraplegias.

Authors:  A E Harding
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

4.  Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia.

Authors:  X Zhao; D Alvarado; S Rainier; R Lemons; P Hedera; C H Weber; T Tukel; M Apak; T Heiman-Patterson; L Ming; M Bui; J K Fink
Journal:  Nat Genet       Date:  2001-11       Impact factor: 38.330

5.  Expression cloning and characterization of a cDNA encoding a novel membrane protein required for the formation of O-acetylated ganglioside: a putative acetyl-CoA transporter.

Authors:  A Kanamori; J Nakayama; M N Fukuda; W B Stallcup; K Sasaki; M Fukuda; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 6.  The acetyl-CoA transporter family SLC33.

Authors:  Yoshio Hirabayashi; Akiko Kanamori; Kazuko H Nomura; Kazuya Nomura
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

7.  NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6).

Authors:  Shirley Rainier; Jing-Hua Chai; Debra Tokarz; Robert D Nicholls; John K Fink
Journal:  Am J Hum Genet       Date:  2003-09-23       Impact factor: 11.025

8.  A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10).

Authors:  Evan Reid; Mark Kloos; Allison Ashley-Koch; Lori Hughes; Simon Bevan; Ingrid K Svenson; Felicia Lennon Graham; Perry C Gaskell; Andrew Dearlove; Margaret A Pericak-Vance; David C Rubinsztein; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2002-09-24       Impact factor: 11.025

9.  Novel mutations in the Atlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to the SPG3A locus.

Authors:  S M Sauter; W Engel; L M Neumann; J Kunze; J Neesen
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

10.  REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.

Authors:  Christian Beetz; Rebecca Schüle; Tine Deconinck; Khanh-Nhat Tran-Viet; Hui Zhu; Berry P H Kremer; Suzanna G M Frints; Wendy A G van Zelst-Stams; Paula Byrne; Susanne Otto; Anders O H Nygren; Jonathan Baets; Katrien Smets; Berten Ceulemans; Bernard Dan; Narasimhan Nagan; Jan Kassubek; Sven Klimpe; Thomas Klopstock; Henning Stolze; Hubert J M Smeets; Constance T R M Schrander-Stumpel; Michael Hutchinson; Bart P van de Warrenburg; Corey Braastad; Thomas Deufel; Margaret Pericak-Vance; Ludger Schöls; Peter de Jonghe; Stephan Züchner
Journal:  Brain       Date:  2008-03-05       Impact factor: 13.501

View more
  46 in total

1.  An analysis of exome sequencing for diagnostic testing of the genes associated with muscle disease and spastic paraplegia.

Authors:  Cristina Dias; Murat Sincan; Praveen F Cherukuri; Rosemarie Rupps; Yan Huang; Hannah Briemberg; Kathryn Selby; James C Mullikin; Thomas C Markello; David R Adams; William A Gahl; Cornelius F Boerkoel
Journal:  Hum Mutat       Date:  2012-02-28       Impact factor: 4.878

Review 2.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks.

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Gabriel Novaes de Rezende Batistella; Thiago Bortholin; Acary Souza Bulle Oliveira
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 3.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

4.  Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia.

Authors:  Elodie Martin; Rebecca Schüle; Katrien Smets; Agnès Rastetter; Amir Boukhris; José L Loureiro; Michael A Gonzalez; Emeline Mundwiller; Tine Deconinck; Marc Wessner; Ludmila Jornea; Andrés Caballero Oteyza; Alexandra Durr; Jean-Jacques Martin; Ludger Schöls; Chokri Mhiri; Foudil Lamari; Stephan Züchner; Peter De Jonghe; Edor Kabashi; Alexis Brice; Giovanni Stevanin
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  The endoplasmic reticulum-based acetyltransferases, ATase1 and ATase2, associate with the oligosaccharyltransferase to acetylate correctly folded polypeptides.

Authors:  Yun Ding; Cosma D Dellisanti; Mi Hee Ko; Cynthia Czajkowski; Luigi Puglielli
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

7.  Mutations in SLC33A1 cause a lethal autosomal-recessive disorder with congenital cataracts, hearing loss, and low serum copper and ceruloplasmin.

Authors:  Peter Huppke; Cornelia Brendel; Vera Kalscheuer; Georg Christoph Korenke; Iris Marquardt; Peter Freisinger; John Christodoulou; Merle Hillebrand; Gaele Pitelet; Callum Wilson; Ursula Gruber-Sedlmayr; Reinhard Ullmann; Stefan Haas; Orly Elpeleg; Gudrun Nürnberg; Peter Nürnberg; Shzeena Dad; Lisbeth Birk Møller; Stephen G Kaler; Jutta Gärtner
Journal:  Am J Hum Genet       Date:  2012-01-13       Impact factor: 11.025

8.  Huppke-Brendel syndrome in a seven months old boy with a novel 2-bp deletion in SLC33A1.

Authors:  Shwetha Chiplunkar; Parayil Sankaran Bindu; Madhu Nagappa; Cheminikara Bineesh; Periyasamy Govindaraj; Narayanappa Gayathri; M M Srinivas Bharath; Hanumanthapura R Arvinda; Pavagada S Mathuranath; Sanjib Sinha; Arun B Taly
Journal:  Metab Brain Dis       Date:  2016-06-15       Impact factor: 3.584

Review 9.  Lysine acetylation in the lumen of the ER: a novel and essential function under the control of the UPR.

Authors:  Mariana Pehar; Luigi Puglielli
Journal:  Biochim Biophys Acta       Date:  2012-12-13

Review 10.  Nε-lysine acetylation in the endoplasmic reticulum - a novel cellular mechanism that regulates proteostasis and autophagy.

Authors:  Mark A Farrugia; Luigi Puglielli
Journal:  J Cell Sci       Date:  2018-11-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.